Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    July 2019
  1. STEWART OA, Kingsbery J, Chang S
    Outbreak in New York! Measles Hepatitis.
    Am J Gastroenterol. 2019 Jul 16. doi: 10.14309/ajg.0000000000000325.
    PubMed     Text format    


    May 2019
  2. PEARLMAN B, Perrys M, Hinds A
    Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection.
    Am J Gastroenterol. 2019 May 8. doi: 10.14309/ajg.0000000000000248.
    PubMed     Text format     Abstract available


  3. BZOWEJ NH, Tran TT, Li R, Belle SH, et al
    Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
    Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000221.
    PubMed     Text format     Abstract available


    April 2019
  4. KIM AY
    Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions.
    Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000231.
    PubMed     Text format     Abstract available


    January 2019
  5. LIN PA, Tseng SH, Huang YH
    Corneal Transplantation From Donors With Hepatitis B: Preliminary Results.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000052.
    PubMed     Text format    


  6. LAIQUE SN, Vargas HE
    Hepatitis C Virus: No Longer a Barrier to Oncology Care.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000095.
    PubMed     Text format     Abstract available


    November 2018
  7. STERLING RK, Wahed AS, King WC, Kleiner DE, et al
    Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0409.
    PubMed     Text format     Abstract available


  8. TORRES HA, Economides MP, Angelidakis G, Hosry J, et al
    Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0383.
    PubMed     Text format     Abstract available


    October 2018
  9. PAN XB, Lu YQ, Lin SZ, Ye J, et al
    An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0248.
    PubMed     Text format     Abstract available


  10. YEE HS, Burton MJ, Belperio PS, Morgan TR, et al
    The Veterans Affairs Hepatitis C Treatment Considerations.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0231.
    PubMed     Text format    


  11. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    PubMed     Text format     Abstract available


    July 2018
  12. REDMAN JS, Sterling RK
    Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.
    Am J Gastroenterol. 2018 Jul 24. pii: 10.1038/s41395-018-0201.
    PubMed     Text format     Abstract available


  13. YOUNOSSI ZM
    Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status.
    Am J Gastroenterol. 2018 Jul 18. pii: 10.1038/s41395-018-0200.
    PubMed     Text format     Abstract available


    June 2018
  14. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed     Text format    


  15. CUADRADO A, Llerena S, Cobo C, Pallas JR, et al
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0157.
    PubMed     Text format     Abstract available


  16. KRAWCZYK M, Gaweda B, Kosnik A, Rejowski S, et al
    Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0078.
    PubMed     Text format    


  17. PHILIPS CA, Paramaguru R, Augustine P
    Severe Alcoholic Hepatitis in a Teetotaler.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0154.
    PubMed     Text format    


  18. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    PubMed     Text format     Abstract available


    May 2018
  19. SCHMELTZER PA, Russo MW
    Clinical narrative: autoimmune hepatitis.
    Am J Gastroenterol. 2018 May 14. pii: 10.1038/s41395-018-0058.
    PubMed     Text format     Abstract available


    April 2018
  20. ZAMOR PJ, Vierling J, Ghalib R, Luketic V, et al
    Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
    Am J Gastroenterol. 2018 Apr 26. pii: 10.1038/s41395-018-0053.
    PubMed     Text format     Abstract available


  21. PERRELLA A, Rinaldi L, Galeota-Lanza A, Izzi A, et al
    DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0062.
    PubMed     Text format    


    March 2018
  22. WONG RJ, Jain MK, Therapondos G, Shiffman ML, et al
    Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0033.
    PubMed     Text format     Abstract available


    February 2018
  23. YI W, Pan CQ, Li MH, Wan G, et al
    The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0010.
    PubMed     Text format     Abstract available


    January 2018
  24. WEN JW, Kohn MA, Wong R, Somsouk M, et al
    Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg2017456. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    December 2017
  25. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  26. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  27. UMASHANKER R
    Continuing Medical Education Questions: December 2017: Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017;112:1789.
    PubMed     Text format    


  28. NGUYEN MH, Trinh H, Do S, Nguyen T, et al
    Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naive or Experienced Patients.
    Am J Gastroenterol. 2017;112:1824-1831.
    PubMed     Text format     Abstract available


    November 2017
  29. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  30. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed     Text format    


  31. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed     Text format    


  32. FUKUI N, Golabi P, Otgonsuren M, Mishra A, et al
    Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
    Am J Gastroenterol. 2017;112:1700-1708.
    PubMed     Text format     Abstract available


    October 2017
  33. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  34. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


    September 2017
  35. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Sep 12. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  36. HUANG R, Yan X, Liu Y, Zhang Z, et al
    Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Am J Gastroenterol. 2017;112:1477-1478.
    PubMed     Text format    


  37. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Text format     Abstract available


  38. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Text format     Abstract available


    August 2017
  39. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  40. MARTIN P, Fabrizi F
    Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
    Am J Gastroenterol. 2017;112:1309-1310.
    PubMed     Text format     Abstract available


  41. EMERY JS, Kuczynski M, La D, Almarzooqi S, et al
    Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Am J Gastroenterol. 2017;112:1298-1308.
    PubMed     Text format     Abstract available


    July 2017
  42. PELLICANO R
    Is Viral Hepatitis Decreasing in the United States?
    Am J Gastroenterol. 2017;112:1170.
    PubMed     Text format    


    June 2017
  43. TOYODA H, Kumada T, Tada T
    Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy.
    Am J Gastroenterol. 2017;112:969-970.
    PubMed     Text format    


    April 2017
  44. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  45. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  46. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  47. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    Corrigendum: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017;112:666.
    PubMed     Text format    


    February 2017
  48. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    


    January 2017
  49. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  50. KWO PY, Cohen SM, Lim JK
    ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Am J Gastroenterol. 2017;112:18-35.
    PubMed     Text format     Abstract available


    August 2016
  51. TROJAN J, Sarrazin C
    Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
    Am J Gastroenterol. 2016;111:1208-9.
    PubMed     Text format    


    July 2016
  52. DI COSTANZO GG, Marino Marsilia G, Tortora R, Di Costanzo G, et al
    Hepatocellular Carcinoma With Peliosis-Like Change-Mimicking Hemangioma: A LI-RADS Exception.
    Am J Gastroenterol. 2016;111:1038-40.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: